<DOC>
	<DOCNO>NCT02099552</DOCNO>
	<brief_summary>The proposed natural history study enroll male female patient , age 36 month young , diagnosis XLHED base genetic test receive investigational study drug . The study protocol include collection relevant medical history documentation clinical outcome use age-appropriate , minimally invasive technology . Data collect retrospectively , back pregnancy assessment may available , prospectively age 5 yr .</brief_summary>
	<brief_title>Natural History Outcomes X-Linked Hypohidrotic Ectodermal Dysplasia</brief_title>
	<detailed_description>Important development regulatory approval therapy XLHED collection data clinical history prospective health affect XLHED . The proposed natural history study enroll male female patient , age 36 month young , diagnosis XLHED base genetic test receive investigational study drug . The study protocol include collection relevant medical history documentation clinical outcome use age-appropriate , minimally invasive technology . Data collect retrospectively , back pregnancy assessment may available , prospectively age 5 yr . Genotype-phenotype correlation XLHED , base well-documented health record prospective assessment genetically-confirmed individual , may provide new clinically-predictive information benefit patient , family , health care provider clinical investigator design trial therapeutic intervention .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Ectodermal Dysplasia</mesh_term>
	<mesh_term>Ectodermal Dysplasia 1 , Anhidrotic</mesh_term>
	<criteria>Subjects must meet follow criterion enrol study : 1 . Confirmed genetic diagnosis XLHED 2 . Written inform consent parent ( reasonably available ) Subjects meet follow criterion enrol study : 1 . Medicallysignificant complication congenital anomaly outside consider associated diagnosis status XLHED 2 . Having receive investigational study drug prior enrollment . For subject le 6 month age , mother take investigational drug pregnancy . 3 . Known hypersensitivity pilocarpine pilocarpinelike muscarinic agonist 4 . Presence pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>X-Linked hypohidrotic ectodermal dysplasia</keyword>
	<keyword>XLHED</keyword>
	<keyword>Hypohidrotic ectodermal dysplasia</keyword>
	<keyword>HED</keyword>
	<keyword>Christ-Siemens-Touraine syndrome</keyword>
</DOC>